Skip to content

Partner Michael Friedland authored the article, “Questions to Ask to Avoid Exclusion of Trademark Surveys,” which was published in IP Watchdog. The article discusses things counsel should consider when working with an expert…

Partners Paul Stewart and Michael Friedland authored, “The Fed. Circ. In July: A ‘Prior Art’ Decision to Know”, part of a monthly series published in Law360 on noteworthy Federal Circuit…

Partners Damien Howard and Vlad Teplitskiy and summer associate Luke Holbrook co-authored the article “Medical Device Cybersecurity Developments,” which was published by Thomson Reuters in Westlaw Today. In the article, Howard and Teplitskiy discuss cybersecurity…

Partners Damien Howard and Vlad Teplitskiy co-authored the article “How to Decide Where to File Patent Applications,” which was published in Electronic Design. The article addresses how to decide where to…

Partner Michael Friedland authored the article, “Be thorough and creative in selecting experts in trademark cases,” which was published in the Daily Journal. The article discusses the different types of professionals that…

Partner Mauricio Uribe and Knobbe Martens summer associate Melis Tirhi co-authored the article, “Good Faith Doctrine and NFTs – How a Bored Ape NFT Dilemma May Present Unique Copyright and Contract Issues,”…

Partner Paul Stewart authored, “The Fed. Circ. In June: A Few Decisions To Know”, which was published in Law360. “The U.S. Court of Appeals for the Federal Circuit issued a…

Partner Mauricio Uribe authored the article, “Monkey business: Seth Green’s bored ape NFT and a barrel of IP issues,” which was published in World Intellectual Property Review. The article addresses the…

Partner Mauricio Uribe authored, “NDAs Remain a Potent Business Tool,” which was published in MedTech Intelligence. Excerpt: “Nondisclosure Agreements (NDAs) are one of the core legal documents that most, if not all,…

Partners Stephen Larson and Adam Powell authored “FTC v. Endo Pharms., Inc.: The D.C. District Court ‘Treads [the] Tenuous Line Between Patent and Antitrust Laws’ to Reject the FTC’s Challenge…

Older posts
- Newer posts